153 related articles for article (PubMed ID: 2524392)
21. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
Jenck F; Broekkamp CL; Van Delft AM
Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
Martin P; Beninger RJ; Hamon M; Puech AJ
Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
[TBL] [Abstract][Full Text] [Related]
23. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze.
Zanoveli JM; Nogueira RL; Zangrossi H
Eur J Pharmacol; 2003 Jul; 473(2-3):153-61. PubMed ID: 12892833
[TBL] [Abstract][Full Text] [Related]
24. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.
Sprouse JS; Aghajanian GK
Neuropharmacology; 1988 Jul; 27(7):707-15. PubMed ID: 2901680
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour.
Fernández-Guasti A; Escalante AL; Ahlenius S; Hillegaart V; Larsson K
Eur J Pharmacol; 1992 Jan; 210(2):121-9. PubMed ID: 1534765
[TBL] [Abstract][Full Text] [Related]
26. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity.
Doods HN; Kalkman HO; De Jonge A; Thoolen MJ; Wilffert B; Timmermans PB; Van Zwieten PA
Eur J Pharmacol; 1985 Jun; 112(3):363-70. PubMed ID: 3160596
[TBL] [Abstract][Full Text] [Related]
27. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
[TBL] [Abstract][Full Text] [Related]
28. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
[TBL] [Abstract][Full Text] [Related]
29. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
30. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
Chaouloff F; Baudrie V; Layeillon C; Broqua P
Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
[TBL] [Abstract][Full Text] [Related]
31. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
32. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
Tricklebank MD; Forler C; Fozard JR
Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus properties of the serotonergic compound eltoprazine.
Ybema CE; Slangen JL; Olivier B; Mos J
J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
[TBL] [Abstract][Full Text] [Related]
34. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion.
Lucki I
J Pharmacol Exp Ther; 1988 Dec; 247(3):1120-7. PubMed ID: 2974486
[TBL] [Abstract][Full Text] [Related]
35. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
36. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
[TBL] [Abstract][Full Text] [Related]
37. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
38. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
Fasmer OB; Berge OG; Post C; Hole K
Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
[TBL] [Abstract][Full Text] [Related]
39. Discriminative stimulus properties of flesinoxan.
Ybema CE; Slangen JL; Olivier B; Mos J
Pharmacol Biochem Behav; 1990 Apr; 35(4):781-4. PubMed ID: 2140607
[TBL] [Abstract][Full Text] [Related]
40. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
